Dr. Hiroshi Hayashi

Thoracic medical oncologist · LMU Klinikum München · Germany (DE) · Oncology

Tier 1STK-0033GoodOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC
Scientific interests: Brain metastases
Engagement preference: Virtual
Advisory boards: 1
Publications: 215
Source system: Manual
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 19 Apr 2026 (149 days ago)
Next planned contact: 19 Jul 2026 Overdue
Last 6 months vs target: 50%
1 of 2 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
19 Apr 2026	Scientific exchange	Phone	Mei Tanaka	Vantrexa	Sequencing after progression	0	—	Reviewed	ENG-0101

Timeline

19 Apr 2026
Scientific exchange
Sequencing after progression

Related stakeholders (8)

LMU Klinikum München

Dr. Hiroshi Kimura
Radiation oncologist
Tier 1
Dr. Benedikt Dubois
Thoracic medical oncologist
Tier 2
Dr. Daniel Vogel
Academic nephrologist
Tier 3
Dr. Paola Jensen
Community nephrologist
Tier 2
Dr. Ingrid Petit
Headache specialist
Tier 3
Dr. Quentin Ueda
Allergist
Tier 2
Dr. Ximena Fischer
Dermatologist
Tier 2
Dr. Gabriel Tanaka
Allergist
Tier 2